[ad_1] Advisors Capital Management LLC lifted its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 24.3% in the first quarter, according to the...
[ad_1] Pfizer Stock Gains After Earnings Beat. Revenue and Outlook Aren’t So Good. [ad_2] Source link
[ad_1] Kestra Advisory Services LLC lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 14.8% during the fourth quarter, Holdings Channel reports....
[ad_1] Plimoth Trust Co. LLC lowered its position in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 3.7% during the 4th quarter, according to its most recent...
[ad_1] Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp,...
[ad_1] Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t...
[ad_1] WSJ News Exclusive Business U.S. biotechnology company was the last of three suitors standing in an auction for Horizon [ad_2] Source link
[ad_1] The Dow Jones Industrial Average has been criticized by some market watchers for being a poor barometer of equity-market performance given its relatively small sample...